Drug Target Discovery and Integration

Drug Target was discovered by identifying the active ingredient from traditional remedies or by serendipitous discovery, as with penicillin. More recently, chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that had a desirable therapeutic effect in a process known as classical pharmacology. After sequencing of the human genome allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease-modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy. Modern drug discovery and Integration involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, the process of drug development can continue, and, if successful, clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design.

 

    Related Conference of Drug Target Discovery and Integration

    October 21-22 2019

    25th World Congress on Advanced Materials

    Singapore
    February 24-25, 2020

    5th Annual Conference and Expo on Biomaterials

    Berlin, Germany
    March 05-06, 2019

    14th Annual Conference on Stem Cell and Biomaterials

    | Prague ,Czech Republic
    March 16-17, 2020

    World Congress on Carbon and Advanced Energy Materials

    Sydney, Australia
    May 24-25, 2021

    4th Global Meeting on Diabetes and Endocrinology

    Istanbul, Turkey

    Drug Target Discovery and Integration Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in